These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16489085)

  • 21. The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia.
    Hogge DE; Feuring-Buske M; Gerhard B; Frankel AE
    Leuk Res; 2004 Nov; 28(11):1221-6. PubMed ID: 15380349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroviral immunotoxin gene therapy of acute myelogenous leukemia in mice using cytotoxic T cells transduced with an interleukin 4/diphtheria toxin gene.
    Vallera DA; Jin N; Baldrica JM; Panoskaltsis-Mortari A; Chen SY; Blazar BR
    Cancer Res; 2000 Feb; 60(4):976-84. PubMed ID: 10706113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein.
    Frankel AE; Beran M; Hogge DE; Powell BL; Thorburn A; Chen YQ; Vallera DA
    Exp Hematol; 2002 Nov; 30(11):1316-23. PubMed ID: 12423685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
    Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
    Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
    Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential signalling for enhanced hexose uptake by interleukin (IL)-3 and IL-5 in male germ cells.
    Rauch MC; Brito M; Zambrano A; Espinoza M; Pérez M; Yañez A; Rivas CI; Slebe JC; Vera JC; Concha II
    Biochem J; 2004 Jul; 381(Pt 2):495-501. PubMed ID: 15018615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo biotherapy of HL-60 myeloid leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor.
    Perentesis JP; Gunther R; Waurzyniak B; Yanishevski Y; Myers DE; Ek O; Messinger Y; Shao Y; Chelstrom LM; Schneider E; Evans WE; Uckun FM
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2217-27. PubMed ID: 9815618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
    Frankel AE; Lilly M; Kreitman R; Hogge D; Beran M; Freedman MH; Emanuel PD; McLain C; Hall P; Tagge E; Berger M; Eaves C
    Blood; 1998 Dec; 92(11):4279-86. PubMed ID: 9834234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
    Muranyi AL; Dedhar S; Hogge DE
    Exp Hematol; 2009 Apr; 37(4):450-60. PubMed ID: 19302919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cells.
    Chadwick DE; Williams DP; Niho Y; Murphy JR; Minden MD
    Leuk Lymphoma; 1993 Oct; 11(3-4):249-62. PubMed ID: 7505148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
    Potala S; Verma RS
    J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing anti-DT IgG concentrations to improve the efficacy of a diphtheria fusion protein.
    Hall PD; Beagle KL; Garrett-Mayer E; Frankel AE
    Anticancer Drugs; 2008 Nov; 19(10):1007-11. PubMed ID: 18827566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cells.
    Sweeney EB; Foss FM; Murphy JR; vanderSpek JC
    Bioconjug Chem; 1998; 9(2):201-7. PubMed ID: 9548535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
    Vercauteren S; Zapf R; Sutherland H
    Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor.
    Perentesis JP; Waddick KG; Bendel AE; Shao Y; Warman BE; Chandan-Langlie M; Uckun FM
    Clin Cancer Res; 1997 Mar; 3(3):347-55. PubMed ID: 9815691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
    Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
    Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibitory effect of human macrophage inflammatory protein-1 alpha (LD78) on acute myeloid leukemia cells in vitro.
    Basara N; Stosić-Grujicić S; Sefer D; Ivanović Z; Antunović P; Milenković P
    Stem Cells; 1996 Jul; 14(4):445-51. PubMed ID: 8843546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
    Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
    Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.